Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 155
Filtrar
1.
J Endocrinol Invest ; 47(3): 571-583, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-37624484

RESUMEN

PURPOSE: A variable number of tandem repeats (VNTR) in the insulin gene (INS) control region may be involved in type 2 diabetes (T2D). The TH01 microsatellite is near INS and may regulate it. We investigated whether the TH01 microsatellite and INS VNTR, assessed via the surrogate marker single nucleotide polymorphism rs689, are associated with T2D and serum insulin levels in a Mexican population. METHODS: We analyzed a main case-control study (n = 1986) that used univariate and multivariate logistic regression models to calculate the risk conferred by TH01 and rs689 loci for T2D development; rs689 results were replicated in other case-control (n = 1188) and cross-sectional (n = 1914) studies. RESULTS: TH01 alleles 6, 8, 9, and 9.3 and allele A of rs689 were independently associated with T2D, with differences between sex and age at diagnosis. TH01 alleles with ≥ 8 repeats conferred an increased risk for T2D in males compared with ≤ 7 repeats (odds ratio, ≥ 1.46; 95% confidence interval, 1.1-1.95). In females, larger alleles conferred a 1.5-fold higher risk for T2D when diagnosed ≥ 46 years but conferred protection when diagnosed ≤ 45 years. Similarly, rs689 allele A was associated with T2D in these groups. In males, larger TH01 alleles and the rs689 A allele were associated with a significant decrease in median fasting plasma insulin concentration with age in T2D cases; the reverse occurred in controls. CONCLUSION: Larger TH01 alleles and rs689 A allele may potentiate insulin synthesis in males without T2D, a process disabled in those with T2D.


Asunto(s)
Diabetes Mellitus Tipo 2 , Tirosina 3-Monooxigenasa , Femenino , Masculino , Humanos , Secreción de Insulina , Diabetes Mellitus Tipo 2/epidemiología , Diabetes Mellitus Tipo 2/genética , Repeticiones de Minisatélite , Estudios de Casos y Controles , Estudios Transversales , Ayuno , Insulina , Repeticiones de Microsatélite/genética
3.
J Endocrinol Invest ; 46(9): 1911-1921, 2023 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-36862244

RESUMEN

PURPOSE: Vitamin D (VD) deficiency and osteoporosis have become a global public health problem. A variant in the Histidine Ammonia-Lyase (HAL) gene has been associated with VD levels and bone mineral density (BMD). However, whether this variant has an influence on VD levels and BMD in Mexican adults remain unclear. METHODS: This cross-sectional analysis included 1,905 adults participating in the Health Worker Cohort Study and 164 indigenous postmenopausal women from the Metabolic Analysis in an Indigenous Sample (MAIS) cohort. The rs3819817 variant was genotyped by TaqMan probe assay. Total 25 hydroxyvitamin D levels were measured by DiaSorin Liaison. BMD at the different sites was assessed through dual-energy X-ray absorptiometry. Linear and logistic regression models were performed to evaluate the associations of interest. RESULTS: The prevalence of VD deficiency was 41%, showing differences between sexes. Obesity and skin pigmentation were associated with lower levels of VD in males and females. rs3819817-T allele was associated with low levels of 25-hydroxyvitamin D, VD deficiency, and hip and femoral neck BMD values (g/cm2). We found two interactions with VD levels, one between adiposity and rs3819817-T allele (P = 0.017) and another between skin pigmentation and rs3819817-T allele (P = 0.019). In indigenous postmenopausal women, we observed higher VD levels in the southern region compared to the northern region (P < 0.001); however, we did not observe differences by genotype. CONCLUSION: Our findings confirm that the genetic variant rs3819817 has an essential function in VD levels and BMD and suggests a role in skin pigmentation in the Mexican population.


Asunto(s)
Densidad Ósea , Deficiencia de Vitamina D , Masculino , Adulto , Femenino , Humanos , Densidad Ósea/genética , Histidina Amoníaco-Liasa , Adiposidad , Estudios de Cohortes , Estudios Transversales , Pigmentación de la Piel/genética , Vitamina D , Obesidad , Absorciometría de Fotón , Deficiencia de Vitamina D/epidemiología , Deficiencia de Vitamina D/genética , Calcifediol , Nucleótidos
5.
Fisioterapia (Madr., Ed. impr.) ; 44(6): 327-335, nov.- dic. 2022. tab
Artículo en Español | IBECS | ID: ibc-212706

RESUMEN

Introducción: Las enfermedades pulmonares restrictivas presentan alteraciones en la mecánica toracopulmonar, reducción de la capacidad funcional y de la función pulmonar. Se pueden encontrar las alteraciones intrínsecas y extrínsecas donde se ven alterados el intersticio, la expansibilidad torácica e incluso afecciones del parénquima pulmonar. La rehabilitación pulmonar podría beneficiar a pacientes con la condición restrictiva y mejorar su condición funcional. Objetivo Establecer el impacto de la rehabilitación pulmonar en pacientes con compromiso respiratorio restrictivo intrínseco y extrínseco en la disnea, capacidad funcional, ansiedad/depresión y calidad de vida relacionada con la salud. Métodos Estudio descriptivo longitudinal con 50 pacientes con enfermedad pulmonar restrictiva y quienes realizaron rehabilitación pulmonar en una clínica de la ciudad de Cali, Colombia. Los participantes vinculados al estudio fueron separados en dos grupos: el primero con enfermedad restrictiva intrapulmonar (ERI) y el segundo grupo con enfermedad restrictiva extrapulmonar (ERE). Resultados La edad media de los pacientes fue de 53,3años. Entre las enfermedades restrictivas intrapulmonares se presentaron: enfermedad intersticial pulmonar difusa (EPID), postcondición de neumonías o síndrome de dificultad respiratoria aguda (SDRA) y secuelas de tuberculosis pulmonar. Y entre las enfermedades respiratorias extrapulmonares: resección pulmonar, resección de lóbulo pulmonar y resección en cuña. Al finalizar la rehabilitación pulmonar el grupo ERI presentó mejorías estadísticamente significativas en la distancia recorrida, consumo de oxígeno estimado (VO2e), disnea, ansiedad y calidad de vida. El grupo ERE presentó incremento significativo en la distancia recorrida y VO2e (AU)


Introduction: Restrictive lung diseases present alterations in thoracic-pulmonary mechanics, reduced functional capacity and lung function. Intrinsic and extrinsic alterations can be found where the interstitium, thoracic expandability and even lung parenchymal conditions are altered. Pulmonary rehabilitation could benefit patients with the restrictive condition and improve their functional condition. Objective Establish the impact of pulmonary rehabilitation in patients with intrinsic and extrinsic restrictive respiratory compromise on dyspnea, functional capacity, anxiety/depression and health-related quality of life. Methods Longitudinal descriptive study with 50 patients with restrictive lung disease who performed pulmonary rehabilitation in a clinic in the city of Cali, Colombia. The participants linked to the study were separated into two groups, the first with intrapulmonary restrictive disease (IRD) and the second group with extrapulmonary restrictive disease (ERD). Results The mean age of the patients was 53.3years. Among the restrictive intrapulmonary diseases there were: diffuse interstitial lung disease (ILD), post-condition pneumonia and/or acute respiratory distress syndrome (ARDS) and sequelae of pulmonary tuberculosis. Extrapulmonary respiratory diseases: lung resection, pulmonary lobe resection, and wedge resection. At the end of pulmonary rehabilitation, the IRD group presented statistically significant improvements in distance covered, estimated oxygen consumption (VO2e), dyspnea, anxiety, and quality of life. The ERD group presented a significant increase in the distance traveled and VO2e. Conclusion Patients with restrictive lung disease improve the distance traveled, VO2e, dyspnea, anxiety and quality of life; patients with extrapulmonary respiratory disease show improvements in functional capacity (AU)


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Anciano , Enfermedades Pulmonares/rehabilitación , Disnea/rehabilitación , Calidad de Vida , Tolerancia al Ejercicio , Ejercicios Respiratorios/métodos , Estudios Longitudinales
6.
BMC Med Genomics ; 15(1): 224, 2022 10 31.
Artículo en Inglés | MEDLINE | ID: mdl-36316743

RESUMEN

BACKGROUND: To date, only twenty-one cases diagnosed postnatally with mosaic trisomy 12 have been reported. The most frequent phenotypic manifestations are developmental delay, dysmorphic facial features, congenital heart defects, digital alterations, and pigmentary disorders. In the present report, detailed clinical and genetic profiles of three unrelated new patients with mosaic trisomy 12 are described and compared with previously reported cases. CASE PRESENTATION: In the present report, we include the clinical, cytogenetic, and molecular description of three Mexican patients diagnosed postnatally with mosaic trisomy 12. At phenotypic level, the three patients present with developmental delay, dysmorphic facial features, congenital heart defects and skin pigmentary anomalies. Particularly, patient 1 showed unique eye alterations as bilateral distichiasis, triple rows of upper lashes, and digital abnormalities. In patient 2 redundant skin, severe hearing loss, and hypotonia were observed, and patient 3 presented with hypertelorism and telecanthus. Hyperpigmentation with disseminated pigmentary anomalies is a common trait in all of them. The cytogenetic study was carried out under the strict criteria of analysis, screening 50-100 metaphases from three different tissues, showing trisomy 12 mosaicism in at least one of the three different tissues analyzed. With SNParray, the presence of low-level mosaic copy number variants not previously detected by cytogenetics, and uniparental disomy of chromosome 12, was excluded. STR markers allowed to confirm the absence of uniparental disomy as well as to know the parental origin of supernumerary chromosome 12. CONCLUSIONS: The detailed clinical, cytogenetic, and molecular description of these three new patients, contributes with relevant information to delineate more accurately a group of patients that show a heterogeneous phenotype, although sharing the same chromosomal alteration. The possibility of detecting mosaic trisomy 12 is directly associated with the sensitivity of the methodology applied to reveal the low-level chromosomal mosaicism, as well as with the possibility to perform the analysis in a suitable tissue.


Asunto(s)
Trastornos de los Cromosomas , Trisomía , Humanos , Trisomía/genética , Mosaicismo , Disomía Uniparental/diagnóstico , Disomía Uniparental/genética , Trastornos de los Cromosomas/genética , Análisis Citogenético
7.
Hipertens. riesgo vasc ; 37(4): 162-168, oct.-dic. 2020. tab
Artículo en Español | IBECS | ID: ibc-196907

RESUMEN

INTRODUCCIÓN: Un tercio de los pacientes hipertensos cursan con depresión mayor, relación que se asocia con peor pronóstico. El objetivo del estudio fue estimar la asociación entre depresión e hipertensión arterial, así como establecer la posible bidireccionalidad de las condiciones. MATERIALES Y MÉTODOS: Estudio de cohorte retrospectivo. Se incluyeron personas entre 18 y 65 años con hipertensión arterial, depresión o uso de medicamentos para su manejo. Para analizar la antecedencia se realizó un modelo de comorbilidad. Se realizó un análisis bivariado y luego una regresión logística multivariada. La asociación se estimó por medio de la prueba de Chi cuadrado y las razones de disparidad u odds ratios crudas y ajustadas a las demás variables incluidas en el análisis. Se utilizó la prueba de Hosmer-Lemeshow para evaluar la bondad del ajuste. Se utilizó SPSS® V.21 como paquete estadístico. RESULTADOS: En el estudio se incluyeron 1.721 personas. La prevalencia de depresión en pacientes con y sin hipertensión fue de 17,4 y 12,6%, respectivamente, con un riesgo de 43% de hipertensión en personas con depresión. En los pacientes con depresión esta antecedió el diagnóstico de hipertensión en el 64,8% de los casos, y en los pacientes hipertensos el 22,2% fue diagnosticado con depresión posteriormente. La asociación entre hipertensión arterial y depresión mayor permaneció significativa luego de realizar el ajuste con los demás factores de riesgo. CONCLUSIONES: La depresión se encontró como un factor de riesgo de hipertensión arterial, con una relación bidireccional de riesgo entre depresión e hipertensión arterial


INTRODUCTION: A third of hypertensive patients have major depression, a relationship that is associated with a worse prognosis. The objective of the study was to estimate the association between depression and high blood pressure, as well as to establish the possible bidirectionality of the conditions. MATERIALS AND METHODS: Retrospective cohort study. People between 18 and 65 years old with high blood pressure, depression or use of medications for their management were included. To analyze the antecedent, a comorbidity model was performed. A bivariate analysis was performed and then a multivariate logistic regression. The association was estimated using the Chi-square test and the odds ratios that were crude and adjusted to the other variables included in the analysis. The Hosmer-Lemeshow test was used to assess the goodness of fit. SPSS® V.21 was used as the statistical package. RESULTS: A total of 1,721 people were included in the study. The prevalence of depression in patients with and without hypertension was 17.4 and 12.6%, respectively, with a 43% risk of hypertension in people with depression. In patients with depression, it preceded the diagnosis of hypertension in 64.8% of cases and in hypertensive patients, 22.2% were later diagnosed with depression. The association between high blood pressure and major depression remained significant after adjusting for the other risk factors. CONCLUSIONS: Depression was found as a risk factor for high blood pressure, with a 2-way risk relationship between depression and high blood pressure


Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto Joven , Adulto , Persona de Mediana Edad , Anciano , Trastorno Depresivo Mayor/epidemiología , Hipertensión/epidemiología , Estudios de Cohortes , Estudios Retrospectivos , Hipertensión/diagnóstico , Factores de Riesgo , Colombia/epidemiología , Actividad Motora , Modelos Logísticos
8.
Hipertens Riesgo Vasc ; 37(4): 162-168, 2020.
Artículo en Español | MEDLINE | ID: mdl-32675035

RESUMEN

INTRODUCTION: A third of hypertensive patients have major depression, a relationship that is associated with a worse prognosis. The objective of the study was to estimate the association between depression and high blood pressure, as well as to establish the possible bidirectionality of the conditions. MATERIALS AND METHODS: Retrospective cohort study. People between 18 and 65 years old with high blood pressure, depression or use of medications for their management were included. To analyze the antecedent, a comorbidity model was performed. A bivariate analysis was performed and then a multivariate logistic regression. The association was estimated using the Chi-square test and the odds ratios that were crude and adjusted to the other variables included in the analysis. The Hosmer-Lemeshow test was used to assess the goodness of fit. SPSS® v.21 was used as the statistical package. RESULTS: A total of 1,721 people were included in the study. The prevalence of depression in patients with and without hypertension was 17.4 and 12.6%, respectively, with a 43% risk of hypertension in people with depression. In patients with depression, it preceded the diagnosis of hypertension in 64.8% of cases and in hypertensive patients, 22.2% were later diagnosed with depression. The association between high blood pressure and major depression remained significant after adjusting for the other risk factors. CONCLUSIONS: Depression was found as a risk factor for high blood pressure, with a 2-way risk relationship between depression and high blood pressure.


Asunto(s)
Trastorno Depresivo Mayor/epidemiología , Hipertensión/epidemiología , Adolescente , Adulto , Anciano , Estudios de Cohortes , Colombia , Trastorno Depresivo Mayor/complicaciones , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Factores de Riesgo , Adulto Joven
9.
J Endocrinol Invest ; 43(7): 935-946, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-31907821

RESUMEN

PURPOSE: Vitamin D deficiency (VDD) and polymorphisms in the group-specific component (GC) gene are known to be associated in different populations. However, the effects of such genetic variants may vary across different populations. Thus, the objective of this study was to estimate the association between Vitamin D-Binding Protein (VDBP) haplotypes and VDD in mestizo postmenopausal women and Mexican Amerindian ethnic groups. METHODS: This was a cross-sectional study of 726 postmenopausal Mexican women from the Health Workers Cohort Study (HWCS) and 166 postmenopausal women from the Metabolic Analysis in an Indigenous Sample (MAIS) cohort in Mexico. GC polymorphisms (rs7045 and rs4588) were analyzed by TaqMan probes. Serum 25-hydroxyvitamin D [25(OH)D] levels were measured by Chemiluminescent Microparticle Immuno Assay. RESULTS: The prevalence of VDD serum 25(OH)D < 20 ng/mL was 43.7% in mestizo women and 44.6% in indigenous women. In HWCS, the single nucleotide polymorphisms (SNPs) rs7041 and rs4588 were associated with VDD. In addition, women from the HWCS, carrying the haplotypes GC2/2 and GC1f/2 had higher odds of VDD (OR = 2.83, 95% CI 1.14, 7.02; and OR = 2.30, 95% CI 1.40, 3.78, respectively) compared to women with haplotype 1f/1 s. These associations were not statistically significant in the MAIS cohort. CONCLUSIONS: Our results show genetic association of the analyzed SNPs and related haplotypes, on the GC gene, with VDD in mestizo Mexican postmenopausal women. Moreover, a high prevalence of VDD with high genetic variability within the country was observed. Our results support the need for national policies for preventing VDD.


Asunto(s)
Posmenopausia , Deficiencia de Vitamina D/etnología , Deficiencia de Vitamina D/genética , Proteína de Unión a Vitamina D/genética , Anciano , Alelos , Estudios de Cohortes , Estudios Transversales , Etnicidad/genética , Femenino , Frecuencia de los Genes , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad/etnología , Humanos , México/epidemiología , Persona de Mediana Edad , Polimorfismo de Nucleótido Simple , Grupos de Población/etnología , Grupos de Población/genética , Posmenopausia/sangre , Posmenopausia/etnología , Posmenopausia/genética , Vitamina D/análogos & derivados , Vitamina D/sangre , Deficiencia de Vitamina D/sangre
10.
Int J Infect Dis ; 91: 17-21, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31669141

RESUMEN

BACKGROUND: Occult hepatitis B virus infection (OBI) is defined as the presence of hepatitis B virus (HBV) DNA in serum and/or liver from HBsAg-negative subjects. Our aim was to determine OBI frequency in serum and genomic DNA in patients undergoing renal transplant and their cognate donors in a selected population from Western Mexico. METHODS: Blood samples were obtained from 94 donors and their cognate recipients (188 participants) before kidney transplantation. Identification of HBV DNA was carried-out by nested (S-region) and semi-nested (Pol-region) PCR in both genomic and serum DNA samples from 188 participants at pre-surgical stage and from a subset of 73 recipients at three-month follow-up. RESULTS: HBV-DNA was not detected in either genomic or serum DNA samples from recipients or donors prior to transplantation. After three-months of follow-up, 2 out of 73 (2.7%, 95% CI: 0.9-11.9%) recipients were positive to HBV-DNA (Pol-region) in genomic DNA samples using a high sensitivity Taq DNA polymerase. CONCLUSIONS: OBI incidence in recipients of kidney transplant may be higher than previously recognized. Detection of HBV-DNA was higher in genomic DNA than in serum samples using a high sensitivity Taq DNA polymerase. To the best of our knowledge, this is the first report regarding this specific topic in Mexicans.


Asunto(s)
ADN Viral/sangre , Hepatitis B/epidemiología , Trasplante de Riñón , Adulto , Femenino , Hepatitis B/sangre , Hepatitis B/virología , Virus de la Hepatitis B/genética , Hepatitis B Crónica , Humanos , Masculino , México , Reacción en Cadena de la Polimerasa , Donantes de Tejidos
11.
Neth Heart J ; 27(9): 392-402, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31111458

RESUMEN

Driven by recent developments in computational power, algorithms and web-based storage resources, machine learning (ML)-based artificial intelligence (AI) has quickly gained ground as the solution for many technological and societal challenges. AI education has become very popular and is oversubscribed at Dutch universities. Major investments were made in 2018 to develop and build the first AI-driven hospitals to improve patient care and reduce healthcare costs. AI has the potential to greatly enhance traditional statistical analyses in many domains and has been demonstrated to allow the discovery of 'hidden' information in highly complex datasets. As such, AI can also be of significant value in the diagnosis and treatment of cardiovascular disease, and the first applications of AI in the cardiovascular field are promising. However, many professionals in the cardiovascular field involved in patient care, education or science are unaware of the basics behind AI and the existing and expected applications in their field. In this review, we aim to introduce the broad cardiovascular community to the basics of modern ML-based AI and explain several of the commonly used algorithms. We also summarise their initial and future applications relevant to the cardiovascular field.

12.
Neth Heart J ; 27(9): 414-425, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31111459

RESUMEN

BACKGROUND: Machine learning (ML) allows the exploration and progressive improvement of very complex high-dimensional data patterns that can be utilised to optimise specific classification and prediction tasks, outperforming traditional statistical approaches. An enormous acceleration of ready-to-use tools and artificial intelligence (AI) applications, shaped by the emergence, refinement, and application of powerful ML algorithms in several areas of knowledge, is ongoing. Although such progress has begun to permeate the medical sciences and clinical medicine, implementation in cardiovascular medicine and research is still in its infancy. OBJECTIVES: To lay out the theoretical framework, purpose, and structure of a novel AI consortium. METHODS: We have established a new Dutch research consortium, the CVON-AI, supported by the Netherlands Heart Foundation, to catalyse and facilitate the development and utilisation of AI solutions for existing and emerging cardiovascular research initiatives and to raise AI awareness in the cardiovascular research community. CVON-AI will connect to previously established CVON consortia and apply a cloud-based AI platform to supplement their planned traditional data-analysis approach. RESULTS: A pilot experiment on the CVON-AI cloud was conducted using cardiac magnetic resonance data. It demonstrated the feasibility of the platform and documented excellent correlation between AI-generated ventricular function estimates as compared to expert manual annotations. The resulting AI solution was then integrated in a web application. CONCLUSION: CVON-AI is a new consortium meant to facilitate the implementation and raise awareness of AI in cardiovascular research in the Netherlands. CVON-AI will create an accessible cloud-based platform for cardiovascular researchers, demonstrate the clinical applicability of AI, optimise the analytical methodology of other ongoing CVON consortia, and promote AI awareness through education and training.

13.
Hum Exp Toxicol ; 38(8): 951-961, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31018701

RESUMEN

The transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) is a master regulator of a battery of antioxidant and detoxificant genes with cytoprotective function. Since Nrf2 inactivation is necessary for the complete execution of apoptosis in the presence of extensive cellular damage caused by oxidative stress, constant activation of Nrf2 may protect tumoral cells from apoptosis. The tumor suppressor gene p53 has been suggested to participate in apoptosis-related repression of Nrf2. Thus, we studied the inactivation of Nrf2 during oxidant-induced apoptosis in a p53 dysfunctional cellular model. Using curcumin dose-response assay and time-response assay in an immortalized lymphoblastoid cell line (control line 45), we observed a time-dependent increase in apoptotic markers such as deoxyribonucleic acid (DNA) fragmentation, phosphatidylserine exposure, and caspase-3, caspase-9 and poly (ADP-ribose) polymerases (PARP) cleavage. Interestingly, at early times of exposure to a proapoptotic dose of curcumin (15 µM), we observed nuclear accumulation of Nrf2 and the expression of Nrf2 target genes, whereas at late exposure times we found a reduction of total and nuclear protein levels of Nrf2 as well as downregulation of Nrf2 target genes in the absence of p53 activation. These data suggest that apoptosis-related inactivation of Nrf2 could occur in a p53 dysfunctional background, opening the possible occurrence of p53-independent mechanism to explain Nrf2 inactivation during apoptosis.


Asunto(s)
Apoptosis/efectos de los fármacos , Curcumina/farmacología , Factor 2 Relacionado con NF-E2/antagonistas & inhibidores , Línea Celular , Supervivencia Celular/efectos de los fármacos , Humanos , Factor 2 Relacionado con NF-E2/metabolismo , Estrés Oxidativo/efectos de los fármacos , Proteína p53 Supresora de Tumor/metabolismo
15.
San José; Federación Centroamericana de Asociaciones y Sociedades de Obstetricia y Ginecología; [2018]. graf, ilus, tab.
Monografía en Español | BIGG - guías GRADE | ID: biblio-964922

RESUMEN

Incluye recomendaciones sobre la prevención y manejo de lesiones premalignas y reducir la incidencia y mortalidad por cáncer cervicouterino.


Asunto(s)
Humanos , Femenino , Lesiones Precancerosas/diagnóstico , Lesiones Precancerosas/terapia , Neoplasias del Cuello Uterino/prevención & control , Neoplasias del Cuello Uterino/terapia , Factores de Riesgo , Infecciones por Papillomavirus/complicaciones
16.
J Immunol Res ; 2017: 6063850, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29214184

RESUMEN

Chronic hepatitis B infection treatment implicates a long-lasting treatment. M. oleifera extracts contain compounds with antiviral, antioxidant, and antifibrotic properties. In this study, the effect of M. oleifera was evaluated in Huh7 cells expressing either HBV genotypes C or H for the antiviral, antifibrotic, anti-inflammatory, and antioxidative responses. Huh7 cells were treated with an aqueous extract of M. oleifera (leaves) at doses of 0, 30, 45, or 60 µg/mL. The replicative virus and TGF-ß1, CTGF, CAT, IFN-ß1, and pgRNA expressions were measured by real time. HBsAg and IL-6 titers were determined by ELISA. CTGF, TGF-ß1, IFN-ß1, and pgRNA expressions decreased with M. oleifera treatment irrespective of the HBV genotype. HBsAg secretion in the supernatant of transfected Huh7 cells with both HBV genotypes was decreased regardless of the dose of M. oleifera. Similar effect was observed in proinflammatory cytokine IL-6, which had a tendency to decrease at 24 hours of treatment. Transfection with both HBV genotypes strongly decreased CAT expression, which is retrieved with M. oleifera treatment. M. oleifera treatment reduced fibrosis markers, IL-6, and HBsAg secretion in HBV genotypes C and H. However, at the level of replication, only HBV-DNA genotype C was slightly reduced with this treatment.


Asunto(s)
Antivirales/farmacología , Carcinoma Hepatocelular/tratamiento farmacológico , Virus de la Hepatitis B/fisiología , Hepatitis B Crónica/tratamiento farmacológico , Neoplasias Hepáticas/tratamiento farmacológico , Moringa oleifera/inmunología , Extractos Vegetales/farmacología , Línea Celular Tumoral , Factor de Crecimiento del Tejido Conjuntivo/genética , Factor de Crecimiento del Tejido Conjuntivo/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Interferón beta/genética , Interferón beta/metabolismo , Interleucina-6/metabolismo , Factor de Crecimiento Transformador beta1/genética , Factor de Crecimiento Transformador beta1/metabolismo , Replicación Viral/efectos de los fármacos
17.
Nat Commun ; 8(1): 1857, 2017 11 30.
Artículo en Inglés | MEDLINE | ID: mdl-29187739

RESUMEN

Atoms interact with each other through the electromagnetic field, creating collective states that can radiate faster or slower than a single atom, i.e., super- and sub-radiance. When the field is confined to one dimension it enables infinite-range atom-atom interactions. Here we present the first report of infinite-range interactions between macroscopically separated atomic dipoles mediated by an optical waveguide. We use cold 87Rb atoms in the vicinity of a single-mode optical nanofiber (ONF) that coherently exchange evanescently coupled photons through the ONF mode. In particular, we observe super-radiance of a few atoms separated by hundreds of resonant wavelengths. The same platform allows us to measure sub-radiance, a rarely observed effect, presenting a unique tool for quantum optics. This result constitutes a proof of principle for collective behavior of macroscopically delocalized atomic states, a crucial element for new proposals in quantum information and many-body physics.

18.
Neuromuscul Disord ; 27(12): 1106-1114, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-29054426

RESUMEN

Myotonic dystrophy type 1 is caused by expansion of a CTG trinucleotide repeat situated in the DMPK gene. Worldwide genetic studies suggest a single or limited number of mutational events cause the disease. However, distribution of CTG alleles and disease incidence varies among ethnicities. Due to the great ethnic diversity of the Mexican population, the present study was aimed at analyzing the impact of different lineages in shaping the CTG-repeat allelic distribution in the contemporary Mexican-Mestizo population as well as to shed light on the DM1 ancestral origin. Distribution of CTG-repeat alleles was similar among Mestizo and Amerindian subpopulations with (CTG)11-13 being the most frequent alleles in both groups, which implies that Mexican-Mestizo allelic distribution has been modeled by Amerindian ancestry. We diagnosed a relatively high number of cases, consistent with the high frequency of large-normal alleles found in Mexican subpopulations. Haplotype analysis using various polymorphic-markers in proximity to DMPK gene indicates that a single founder mutation originates myotonic dystrophy type 1 in Mexico; however, Y-STR haplogroups data and the presence of pre-mutated and large normal alleles in Amerindians support the hypothesis that both European and Amerindian ancestral chromosomes might have introduced the disease to the Mexican population, which was further disseminated through mestizaje.


Asunto(s)
Frecuencia de los Genes/genética , Indígenas Norteamericanos/genética , Distrofia Miotónica/etnología , Distrofia Miotónica/genética , Proteína Quinasa de Distrofia Miotónica/genética , Expansión de Repetición de Trinucleótido/genética , Población Blanca/genética , Efecto Fundador , Humanos , México/etnología
19.
Environ Monit Assess ; 189(10): 522, 2017 Sep 26.
Artículo en Inglés | MEDLINE | ID: mdl-28948473

RESUMEN

The Santiago River is one of the most contaminated rivers in Mexico, with heavy metal levels above the allowed limits. Scientific evidence indicates that chronic heavy metal exposure leads to cytogenotoxic effects. The aims of this study were to evaluate the genotoxic and cytotoxic effects of such exposure in buccal mucosa cells by micronucleus (MN) assay and to identify other nuclear abnormalities (NAs), such as nuclear buds (NBUDs), binucleated cells (BNs), pyknotic nuclei (PNs), karyorrhexis (KX), karyolysis (KL), and abnormally condensed chromatin (CC). Assays were performed on samples from four populations located alongside the Santiago River that are under chronic exposure to heavy metals and other metals (HMMs), and the results were compared with those of a population without exposure to HMMs. The exposed group showed increased frequencies of NAs (KX, CC, and KL), which are associated with cytotoxic damage, and NBUDs, which are associated with genotoxic damage. Increased frequencies of NBUDs and CC were observed in subjects from El Salto/Juanacatlán, Ocotlán, and Paso de Guadalupe, and an increase in KX frequency was observed in subjects from El Salto/Juanacatlán. Significant differences in KL frequency were observed in subjects from La Barca, El Salto/Juanacatlán, Paso de Guadalupe, and Ocotlán. Predictors for increased development of MNs and NBUDs were high concentrations of Al, Zn, and Cu. In conclusion, chronic exposure to HMMs, especially Al, Cu, and Zn, in the studied population could be related to increased frequencies of NAs, such as NBUDs, KX, CC, and KL, in the buccal mucosa cells.


Asunto(s)
Exposición a Riesgos Ambientales/análisis , Contaminantes Ambientales/metabolismo , Metales Pesados/metabolismo , Pruebas de Micronúcleos , Mucosa Bucal/metabolismo , Adulto , Núcleo Celular/efectos de los fármacos , Daño del ADN , Exposición a Riesgos Ambientales/estadística & datos numéricos , Monitoreo del Ambiente , Contaminantes Ambientales/toxicidad , Femenino , Humanos , Masculino , Metales Pesados/toxicidad , México , Ríos
20.
Int J Cardiovasc Imaging ; 33(10): 1483-1489, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28488096

RESUMEN

Low cardiac output syndrome (LCOS) after surgical aortic valve replacement (SAVR) is related to increased mortality and treatment related costs. We aimed to evaluate whether echocardiography-derived left ventricular global longitudinal strain (LV-GLS) relates to the occurrence of postoperative LCOS in patients undergoing SAVR. We prospectively enrolled 75 patients with symptomatic severe aortic stenosis, left ventricular ejection fraction (LVEF) >40%, NYHA Class

Asunto(s)
Estenosis de la Válvula Aórtica/cirugía , Válvula Aórtica/cirugía , Gasto Cardíaco Bajo/diagnóstico por imagen , Ecocardiografía , Implantación de Prótesis de Válvulas Cardíacas/efectos adversos , Función Ventricular Izquierda , Función Ventricular Derecha , Anciano , Válvula Aórtica/diagnóstico por imagen , Válvula Aórtica/fisiopatología , Estenosis de la Válvula Aórtica/diagnóstico por imagen , Estenosis de la Válvula Aórtica/mortalidad , Estenosis de la Válvula Aórtica/fisiopatología , Área Bajo la Curva , Fenómenos Biomecánicos , Gasto Cardíaco Bajo/etiología , Gasto Cardíaco Bajo/mortalidad , Gasto Cardíaco Bajo/fisiopatología , Distribución de Chi-Cuadrado , Femenino , Implantación de Prótesis de Válvulas Cardíacas/mortalidad , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Variaciones Dependientes del Observador , Oportunidad Relativa , Valor Predictivo de las Pruebas , Estudios Prospectivos , Curva ROC , Reproducibilidad de los Resultados , Medición de Riesgo , Factores de Riesgo , Estrés Mecánico , Factores de Tiempo , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...